Neos Therapeutics, Inc
NEOS
NEOS was delisted on the 19th of March, 2021.
45 hedge funds and large institutions have $88.4M invested in Neos Therapeutics, Inc in 2015 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 18 increasing their positions, 8 reducing their positions, and 9 closing their positions.
125% more repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 8
22% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 9
5% more funds holding
Funds holding: 43 → 45 (+2)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
30% less capital invested
Capital invested by funds: $127M → $88.4M (-$38.5M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Franklin Resources
San Mateo,
California
|
+$5.49M |
| 2 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$2.89M |
| 3 |
SCM
Sio Capital Management
New York
|
+$1.73M |
| 4 |
EMFAT
Emerald Mutual Fund Advisers Trust
Leola,
Pennsylvania
|
+$1.22M |
| 5 |
EA
Emerald Advisers
Leola,
Pennsylvania
|
+$868K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TCP
Tourbillon Capital Partners
New York
|
-$12.9M |
| 2 |
PA
Perceptive Advisors
New York
|
-$3.45M |
| 3 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$2.59M |
| 4 |
WRF
Waddell & Reed Financial
Overland Park,
Kansas
|
-$840K |
| 5 |
WSA
Wall Street Associates
Lajolla,
California
|
-$754K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
TRCT
51
Tower Research Capital (TRC)
New York
| – | -$58K | -2,781 | Closed |
|
52
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$4K | -200 | Closed |
|
53
Bank of Montreal
Toronto,
Ontario, Canada
| – | -$1K | -28 | Closed |
|
54
Wells Fargo
San Francisco,
California
| – | -$121 | -8 | -35% |
|
NEOS Hedge Fund Activity: Q4 2015 in Review
45 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Neos Therapeutics, Inc (NEOS) for Q4 2015, worth a combined $88.4M — down 30% from $127M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new NEOS positions and 9 closed out — a net gain of 2 holders — while 18 added to existing stakes and 8 trimmed.
The largest buyer was Franklin Resources, adding an estimated $5.49M. The largest seller was Tourbillon Capital Partners, exiting entirely with an estimated $12.9M sold.
- 45 institutional investors held Neos Therapeutics, Inc (NEOS) as of Q4 2015, up from 43 in Q3 2015.
- Funds reported $88.4M of Neos Therapeutics, Inc stock for Q4 2015, down 30% quarter-over-quarter.
- 11 funds opened new Neos Therapeutics, Inc positions in Q4 2015 and 9 closed out, a net change of +2 holders.
- The largest Neos Therapeutics, Inc buyer in Q4 2015 was Franklin Resources, an estimated $5.49M added.
- The largest Neos Therapeutics, Inc seller in Q4 2015 was Tourbillon Capital Partners, an estimated $12.9M sold.
Based on aggregated 13F filings for Q4 2015.